Humanized Mice Model Market to Hit USD 19.71 Billion By 2031, Due to the Rising Demand for Personalized Medicine | Growth Plus Reports
Growth Plus Reports
7 min read
Growth Plus Reports
Newark, New Castle, USA, March 31, 2023 (GLOBE NEWSWIRE) -- The newest report from Growth Plus Reports analyzes the production, applications, demand, major manufacturers, and SWOT analysis of the global humanized mice model Market.
The humanized mice model market report assists in analyzing the optimum distribution methods for certain products as well as potential markets for new product launches. You can get insights into valuable data, information, statistics, trends, and competitive landscape through the report's comprehensive TOC, Tables, and charts.
Key Takeaways:
The growth in the prevalence of chronic and infectious diseases is driving the market's revenue growth.
The increasing demand for personalized medicine will drive demand for humanized mice models.
North America dominates the global humanized mice model market.
North America, Europe, Asia Pacific, and the Rest of the World (ROW)
Market Drivers The increasing demand for personalized medicine will drive the revenue growth of humanized mice model market. Furthermore, the rising investments in research and development in the life sciences industry, the growing understanding of the necessity of personalized medicine, and the rising demand for targeted therapies are expected to boost the market revenue growth rate. The increased prevalence of chronic and infectious diseases and the need for humanized mice models in the preclinical testing of novel medications and treatments will support the market's revenue growth.
Market Segmentation Growth Plus Reports has analyzed the global humanized mice model market from four perspectives: Model Type, Application, End-user, and Region.
Model Type Segmentation: The global humanized mice model market is segmented into cell-based and genetically humanized mice models based on the model type. The genetic humanized mouse model segment dominates the market because of the widespread application of genetically humanized mice models in compound analysis, biological efficacy and safety testing, medication metabolism and disposition studies, and immune system development and function research.
Application Segmentation: Based on the application, the global humanized mice model market is segmented into Oncology, GvHD, Neuroscience, Toxicology, Regenerative Medicine, Immunology & Infectious Diseases, and Others. The oncology segment dominates the market because of growing cancer prevalence, increasing cancer research and development projects, and rising clinical demand.
End-User Segmentation: Based on the end-user, the global humanized mice model market is segmented into Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations (CROs). The pharmaceutical and biotechnology companies segment dominates the market since mice are widely used as model organisms to test new vaccinations because they have a well-defined genome, characterized immune system, and the capacity to breed fast.
Regional Growth Dynamics Based on the region, the global humanized mice model market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America dominates the global humanized mice model market with the largest revenue share. The presence of several top pharmaceutical and biotechnology companies, world-class research institutions, government support for biomedical research, rising R&D expenditures by biotech and pharmaceutical firms, advances in genetic engineering, and an increasing demand for humanized models in drug discovery and development, cancer research, and immunology research is responsible for North America's significant revenue share in the global market.
Competitive Landscape The major players operating in the global humanized mice model market are:
· Genoway S.A. · Crown Bioscience Inc. · HuMurine Technologies · Yecuris Corporation · Taconic Biosciences Inc. · Ingenious Targeting Laboratory Inc. · Charles River Laboratories Inc. · Horizon Discovery Group Plc · Champions Oncology Inc. · Beijing Vitalstar Biotechnology Co., Ltd
The humanized mice model devices market is slightly competitive, with several international players involved. Market giants focus on technological advancements, R&D activities, mergers, acquisitions, and new product launches to strengthen their market presence.
Recent developments:
GemPharmatech and Charles River Laboratories, Inc. signed a strategic licensing agreement in July 2022 to sell GemPharmatech's NOD CRISPR Prkdc Il2r gamma (NCG)-mouse lines exclusively in North America. Charles River is considering building foundation colonies, with the first models going on sale in early 2023.
The Medical Research Council (MRC) of the United Kingdom formally launched The National Mouse Genetics Network in April 2022 with a 20-million-euro investment. The United Kingdom is expected to profit from its global leadership in biomedical sciences by focusing on mouse genetics for disease modeling by establishing the MRC National Mouse Genetics Network.
Table of Content
INTRODUCTION
Market Ecosystem
Timeline Under Consideration
Historical Years – 2021
Base Year – 2022
Forecast Years – 2023 to 2031
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Data Collection Methodology
Data Sources
Secondary Sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecasting Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trends (COVID-19 Perspective)
Key Players & Competitive Positioning (2022)
Regulatory Landscape
MARKET DYNAMICS
Drivers
Restraints/Challenges
Opportunities
GLOBAL HUMANIZED MICE MODEL MARKET - ANALYSIS & FORECAST, BY MODEL TYPE
Cell-Based Humanized Mice Model
Genetic Humanized Mice Model
GLOBAL HUMANIZED MICE MODEL MARKET - ANALYSIS & FORECAST, BY APPLICATION
Hereditary Spastic Paraplegia Market by Drug Class (Skeletal Muscle Relaxants, Anxiolytics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Outlook and Forecast 2023-2031
Femoral Nail System Market by Patient Type (Pediatric, Adults), Indications (Spiral or Transverse, Comminuted, and Open) - Global Outlook and Forecast 2023-2031
External Fixation System Market by Product (Manual Fixator, Computer-aided Fixators), Type (Unilateral, Bilateral), Application (Orthopedic Deformities, Fracture Fixation), End User (Hospitals, Ambulatory Surgical Centers) - Global Outlook and Forecast 2023-2031
Disposable PPE Market by Product Type (Protective Clothing, Respiratory Protection), End User (Hospitals, Home Healthcare) – Global Outlook & Forecast 2023-2031
Automated Immunoassay Analyzers Market by Product (Immunofluorescence, Chemiluminescence) Application (Infectious Diseases, Endocrinology,) End User (Academic Research Institutes, Biotech and Pharma Companies) – Global Outlook & Forecast 2023-2031
Artificial Cartilage Implants Market by Anatomy of Joints (Upper Extremity Joints, Lower Extremity Joints), End User (Hospitals, Ambulatory Surgical Centers) – Global Outlook & Forecast 2023-2031
Veterinary Imaging Market by Product (X-ray, Ultrasound, MRI), Application (Cardiology, Neurology, Respiratory, Orthopedics, and Traumatology), End Use (Veterinary Hospitals & Clinics, Other End-use)- Global Outlook and Forecast 2023-2031
Rapid Medical Tests Market By Product (Instruments, Consumables), Technology (Immunoassay, Molecular diagnostics), Application (Upper Respiratory Tract Infections), End-user (Hospitals & Clinics) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
